Strong Neuroscience Demand And Pipeline Uncertainties Will Shape Future Opportunities

AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Published
31 Aug 24
Updated
30 Jul 25
AnalystConsensusTarget's Fair Value
US$41.44
35.8% undervalued intrinsic discount
30 Jul
US$26.60
Loading
1Y
-3.3%
7D
-1.5%

Author's Valuation

US$41.4

35.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 15%

Shared on19 Mar 25
Fair value Decreased 3.70%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.

Shared on11 Mar 25
Fair value Decreased 7.34%

AnalystConsensusTarget has increased revenue growth from -1.3% to -2.7% and decreased profit margin from 15.5% to 13.9%.